Testosterone
- Generic Name
- Testosterone
- Brand Names
- Androderm, Androgel, Axiron, Fortesta, Natesto, Striant, Testim, Testopel, Vogelxo
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O2
- CAS Number
- 58-22-0
- Unique Ingredient Identifier
- 3XMK78S47O
- Background
Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.
Testosterone was isolated from samples and also synthesized in 1935.
- Indication
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
- Associated Conditions
- Hypergonadotropic Hypogonadism, Hypogonadotrophic Hypogonadism, Idiopathic Hypogonadotropic Hypogonadism, Puberty, Delayed, Inoperable, metastatic Breast cancer
- Associated Therapies
- -
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
- Conditions
- Interventions
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2008-08-25
- Lead Sponsor
- SELARL du Dr Jacques BUVAT
- Target Recruit Count
- 173
- Registration Number
- NCT00244023
- Locations
- 🇫🇷
CETPARP/SelarlJBuvat, Lille, France
ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 120
- Registration Number
- NCT00202163
- Locations
- 🇨🇦
Centre for Advanced Urological Research, Kingston, Ontario, Canada
Testosterone Effects on Bone and Frailty
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-10-30
- Lead Sponsor
- National Institute on Aging (NIA)
- Target Recruit Count
- 140
- Registration Number
- NCT00182871
- Locations
- 🇺🇸
Center on Aging, University of Connecticut Health Center, Farmington, Connecticut, United States
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
- Conditions
- Interventions
- First Posted Date
- 2005-06-14
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 177
- Registration Number
- NCT00114114
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Bone Loss in Women With Anorexia Nervosa
- Conditions
- Interventions
- First Posted Date
- 2004-08-17
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 77
- Registration Number
- NCT00089843
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Testosterone and Growth Hormone for Bone Loss in Men
- Conditions
- Interventions
- First Posted Date
- 2004-04-06
- Last Posted Date
- 2014-06-13
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 35
- Registration Number
- NCT00080483
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 86
- Registration Number
- NCT00009555
- Locations
- 🇺🇸
Northwestern University CRS, Chicago, Illinois, United States
🇺🇸Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu, Hawaii, United States
🇺🇸University of Colorado Hospital CRS, Aurora, Colorado, United States
Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly
- Conditions
- Interventions
- First Posted Date
- 2001-07-05
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 88
- Registration Number
- NCT00018356
- Locations
- 🇺🇸
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock, No. Little Rock, Arkansas, United States
AIDS Wasting in Women: Anabolic Effects of Testosterone
- Conditions
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Randomized Study of Testosterone and Progressive Resistance Exercise in Men With Burn Injury
- Conditions
- First Posted Date
- 2000-08-04
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 60
- Registration Number
- NCT00006129
- Locations
- 🇺🇸
University of Texas Medical Branch, Galveston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.